文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

非心脏内科住院患者院内高血压的治疗与结局

Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions.
PubMed 文献 · JAMA Intern Med · 2021-01-01
一句话结论非心血管内科住院患者中,无终末器官损害证据时强化降压治疗与更高的急性肾损伤和心肌损伤风险相关。

倾向匹配控制患者和血压特征后,治疗组急性肾损伤(10.3% vs 7.9%,P<.001)和心肌损伤(1.2% vs 0.6%,P=.003)发生率更高,且无任何血压区间治疗组结局优于未治疗组。出院时仅9%患者降压方案强化,且强化与未来1年血压控制改善无关。

要点

  • 非心血管内科住院成人中高血压常见(78%),但急性降压治疗并不常见(33.1%),且无终末器官损害时强化治疗与更差结局相关。
  • 倾向匹配后,治疗组急性肾损伤发生率10.3% vs 未治疗组7.9%(P<.001),心肌损伤1.2% vs 0.6%(P=.003)。
  • 未发现任何血压区间内治疗组结局优于未治疗组,提示院内高血压治疗缺乏获益区间。
  • 出院时降压方案强化仅占9%,且与未来1年血压控制改善无关。
  • 住院期间无终末器官损害证据时,应谨慎强化降压治疗,避免不必要的静脉或口服降压药加用。

适用人群与场景

  • 2017年1月1日至12月31日在Cleveland Clinic Hospitals医疗系统10家医院内科服务住院的成人患者。
  • 排除心血管诊断患者。
  • 纳入非心血管诊断、至少记录到1次高血压血压值的住院成人。
  • 平均年龄65.6岁(SD 17.9),女性56.9%,白人69.9%。

诊断标准与关键阈值

  • 急性高血压治疗定义为给予静脉降压药物或新类别口服降压治疗。
  • 高血压血压值记录:原文未给出具体血压阈值。
  • 原文未提及终末器官损害的具体诊断标准或评分界值。

处置流程与药物剂量

  • 原文未提及具体的降压药物名称、剂量、给药途径、频次或目标值。
  • 原文未给出院内高血压的处理流程或推荐方案。

红旗征与不能漏的情况

  • 原文未提及需要立即处理或不能漏诊的具体红旗征。
  • 原文提示强化降压治疗与急性肾损伤和心肌损伤风险增加相关,但未列出具体预警指标或处理措施。

研究设计与关键结果

  • 研究类型:回顾性队列研究,10家医院,2017年全年,随访1年。
  • 干预与对照:急性降压治疗(静脉降压药或新类别口服降压药)vs 未治疗,采用倾向匹配控制患者和血压特征。
  • 主要终点:倾向匹配样本中各4520例,治疗组急性肾损伤466例(10.3%)vs 未治疗组357例(7.9%),P<.001;心肌损伤53例(1.2%)vs 26例(0.6%),P=.003。
  • 不良事件:原文未提及除急性肾损伤、心肌损伤、卒中以外的其他不良事件。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:观察性设计,可能存在残余混杂;单医疗系统(10家医院);仅纳入内科服务住院患者且排除心血管诊断;原文未提及盲法或失访情况。

对床旁实践的改变

  • 对于非心血管内科住院患者,无终末器官损害证据时,应避免常规强化降压治疗,因与急性肾损伤和心肌损伤风险增加相关。
  • 出院时强化降压方案并未改善未来1年血压控制,不应仅因院内血压升高而常规加用降压药物。
  • 适用人群:非心血管诊断的内科住院成人;不适用人群:心血管诊断患者(原文排除)。
  • 常见陷阱:将院内高血压视为需要立即药物干预的指征,而忽略缺乏终末器官损害证据时的潜在危害。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Despite high prevalence of elevated blood pressure (BP) among medical inpatients, BP management guidelines are lacking for this population. The outcomes associated with intensifying BP treatment in the hospital are poorly studied.

OBJECTIVES: To characterize clinician response to BP in the hospital and at discharge and to compare short- and long-term outcomes associated with antihypertensive treatment intensification.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study took place from January 1 to December 31, 2017, with 1 year of follow-up at 10 hospitals within the Cleveland Clinic Hospitals health care system. All adults admitted to a medicine service in 2017 were evaluated for inclusion. Patients with cardiovascular diagnoses were excluded. Demographic and BP characteristics were used for propensity matching.

EXPOSURES: Acute hypertension treatment, defined as administration of an intravenous antihypertensive medication or a new class of an oral antihypertensive treatment.

MAIN OUTCOMES AND MEASURES: The association between acute hypertension treatment and subsequent inpatient acute kidney injury, myocardial injury, and stroke was measured. Postdischarge outcomes included stroke and myocardial infarction within 30 days and BP control up to 1 year.

RESULTS: Among 22 834 adults hospitalized for noncardiovascular diagnoses (mean [SD] age, 65.6 [17.9] years; 12 993 women [56.9%]; 15 963 White patients [69.9%]), 17 821 (78%) had at least 1 hypertensive BP recorded during their admission. Of these patients, 5904 (33.1%) were treated. A total of 8692 of 106 097 cases (8.2%) of hypertensive systolic BPs were treated; of these, 5747 (66%) were treated with oral medications. In a propensity-matched sample controlling for patient and BP characteristics, treated patients had higher rates of subsequent acute kidney injury (466 of 4520 [10.3%] vs 357 of 4520 [7.9%]; P < .001) and myocardial injury (53 of 4520 [1.2%] vs 26 of 4520 [0.6%]; P = .003). There was no BP interval in which treated patients had better outcomes than untreated patients. A total of 1645 of 17 821 patients (9%) with hypertension were discharged with an intensified antihypertensive regimen. Medication intensification at discharge was not associated with better BP control in the following year.

CONCLUSIONS AND RELEVANCE: In this cohort study, hypertension was common among medical inpatients, but antihypertensive treatment intensification was not. Intensification of therapy without signs of end-organ damage was associated with worse outcomes.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Rastogi R, Sheehan MM, Hu B, et al. Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. JAMA Intern Med. 2021. PMID: 33369614. doi:10.1001/jamainternmed.2020.7501

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。